Benign and Malignant Diseases of the Endometrium

Topics in Magnetic Resonance Imaging

Volumn 14, Issue 4, 2003, Pages 339-357

  Chaudhry, Sidhartha ^a   Reinhold, Caroline ^a,b,c   Guermazi, Ali ^c,d   Khalili, Ida ^a   Maheshwari, Sharad ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c SYNARC INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

CANCER STAGING; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IATROGENIC DISEASE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT CARE; PERITONEUM ADHESION; POLYP; PRIORITY JOURNAL; REVIEW; SARCOMA; TRANSVAGINAL ECHOGRAPHY; UTERUS DISEASE; UTERUS SARCOMA;

ANTINEOPLASTIC AGENTS, HORMONAL; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; POLYPS; SARCOMA; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; UTERINE DISEASES;

EID: 0242384944     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200308000-00006     Document Type: Review

References (100)

1. Reinhold C, Gallix BP, Ascher SM. Uterus and cervix. In: Semelka RC, Ascher SM, Reinhold C, eds. MRI of the Abdomen and Pelvis: A Text Atlas. New York: Wiley-Liss, 1997;585-660.
2. Mitchell DG, Schonholz L, Hilpert PL, et al. Zones of the uterus: Discrepancy between US and MR images.. Radiology 1990;174(3 pt 1):827-831.
3. McCarthy S, Tauber C, Gore J. Female pelvic anatomy: MR assessment of variations during the menstrual cycle and with use of oral contraceptives. Radiology 1986;160:119-123.
4. Scoutt LM, Flynn SD, Luthringer DJ, et al. Junctional zone of the uterus: Correlation of MR imaging and histologic examination of hysterectomy specimens. Radiology 1991;179:403-407.
5. Haynor DR, Mack LA, Soules MR, et al. Changing appearance of the normal uterus during the menstrual cycle: MR studies. Radiology 1986;161:459-462.
6. McCarthy SM, Scott LM. In: Stark DD, Bradley WJ Jr., eds. Magnetic Resonance Imaging, 3rd ed. St. Louis, Mosby-Year Book, 1999;557-590.
7. Demas BE, Hricak H, Jaffe RB. Uterine MR imaging: Effects of hormonal stimulation. Radiology 1986;159:123-126.
8. Kasai M. Clinical application of magnetic resonance imaging (MRI) in uterine disease. Nippon Sanka Fujinka Gakkai Zasshi 1990;42:711-718.
9. Lee JK, Gersell DJ, Balfe DM, et al. The uterus: In vitro MR-anatomic correlation of normal and abnormal specimens. Radiology 1985;157:175-179.
10. Hricak H, Alpers C, Crooks LE, et al. Magnetic resonance imaging of the female pelvis: Initial experience. Am J Roentgenol 1983; 141:1119-1128.
11. Yamashita Y, Harada M, Sawada T, et al. Normal uterus and FIGO stage I endometrial carcinoma: Dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:495-501.
12. Kubic-Huch RA, Reinhold C, Semelka RC. Uterus and cervix. In: Semelka RC. Abdominal-Pelvic MRI. New York: Wiley-Liss, 2002;1049-1122.
13. Hricak H. Current trends in MR imaging of the female pelvis. Radiographics 1993;13:913-919.
14. Smith RC, Reinhold C, McCauley TR, et al. Multicoil high-resolution fast spin-echo MR imaging of the female pelvis. Radiology 1992;184:671-675.
15. deSouza NM, Hawley IC, Schwieso JE, et al. The uterine cervix on in vitro and in vivo MR images: A study of zonal anatomy and vascularity using an enveloping cervical coil. Am J Roentgenol 1994; 163:607-612.
16. Sturdee DW, Barlow DH, Ulrich LG, et al. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestogen replacement therapy? Lancet 1994;344: 979-982.
17. Sturdee DW, Ulrich LG, Barlow DH, et al. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. Br J Obstet Gynaecol 2000;107: 1392-1400.
18. Savitski GA. Local hyperestradiolemia of the uterus in the pathogenesis of hyperplastic endometrial processes. Vopr Onkol 1991; 37:179-184.
19. Salem S. In: Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic Ultrasound, 2nd ed. St. Louis: Mosby-Year Book, 1998;575-598.
20. Kurman RJ. Blaustein's Pathology of the Female Genital Tract, 4th ed. New York: Springer-Verlag, 1994;439-487.
21. Karakitsos P, Kyroudes A, Pouliakis A, et al. Potential of the learning vector quantizer in the cell classification of endometrial lesions in postmenopausal women. Anal Quant Cytol Histol 2002;24: 30-38.
22. Wells M, Sturdee DW, Barlow DH, et al. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: Follow up study. BMJ 2002; 325:239.
23. Kurjak A, Shalan H, Kupesic S, et al. An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed doppler sonography. J Ultrasound Med 1994; 13:295-301.
24. Scoutt LM, McCarthy SM, Flynn SD, et al. Clinical stage I endometrial carcinoma: Pitfalls in preoperative assessment with MR imaging. Radiology 1995;194:567-572.
25. Reid PC, Brown VA, Fothergill DJ. Outpatient investigation of postmenopausal bleeding. Br J Obstet Gynaecol 1993; 100:498.
26. Ramondetta LM, Sherwood J, Dunton C, et al. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol 1999;180(2 pt 1):340-341.
27. Karlsson B, Granberg S, Wikland M, et al. Endovaginal scanning of the endometrium compared with cytology and histology in women with postmenopausal bleeding. Gynecol Oncol 1993;50: 173-178.
28. Nolan JF, Huen A. Prognosis in endometrial cancer. Gynecol Oncol 1976;4:384-390.
29. Ascher SM, Imaoka I, Lage JM. Tamoxifen-induced uterine abnormalities: The role of imaging. Radiology 2000;214:29-38.
30. McGonigle KF, Shaw SL, Vasilev SA, et al. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. Am J Obstet Gynecol 1998;178:1145-1150.
31. Sheth S, Hamper UM, Kurman RJ. Thickened endometrium in the postmenopausal woman: Sonographic-pathologic correlation. Radiology 1993;187:135-139.
32. Pertl B, Lahousen M, Pieber D, et al. Stellenwert der Sonograhie bei der Früherkennung des Endometriumkarzinoms. Gynakol Geburtshilfliche Rundsch 1996;36:14-20.
33. Grasel RP, Outwater EK, Siegelman ES, et al. Endometrial polyps: MR imaging features and distinction from endometrial carcinoma. Radiology 2000;214:47-52.
34. Hricak H, Finck S, Honda G, et al. MR imaging in the evaluation of benign uterine masses: Value of gadopentetate dimeglumine-enhanced T1-weighted images. Am J Roentgenol 1992;158:1043-1050.
35. Kolata G, Fisher LM. Drugs to fight breast cancer near approval. The New York Times September 3, 1998:A1, A18.
36. Mourits MJ, Ten Hoor KA, van der Zee AG, et al. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol 2002;55 514-519.
37. Uziely B, Lewin A, Brufman G, et al. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 1993;26:101-105.
38. Juneja M, Jose R, Kekre AN, et al. Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma. Int J Gyneacol Obstet 2002;76:279-284.
39. Kurman RJ, Norris HJ. Endometrial hyperplasia and related cellular changes. In: Kurman RJ, eds. Blaustein's Pathology of the Female Genital Tract, 4th ed. New York: Springer-Verlag, 1994;411-437.
40. Lahti E, Blanco G, Kaupplia A, et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81:660-664.
41. Cohen I, Beyth Y, Shapira J, et al. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 1997;44:200-205.
42. Choyke PL, Thickman D, Kressel HY, et al. Controversies in the radiologic diagnosis of pelvic malignancies. Radiol Clin North Am 1985;23:531-549.
43. Reinhold C, Khalili I. Postmenopausal bleeding: Value of imaging. Radiol Clin North Am 2002;40:527-562.
44. Salem S. The uterus and adnexa. In: Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic Ultrasound, 2nd ed. St. Louis: Mosby-Year Book, 1998;535-540.
45. Cullinan JA, Fleischer AC, Kepple DM, et al. Sonohysterography: A technique for endometrial evaluation. Radiographics 1995;15: 501-514.
46. Doren M, Suelbeck B, Schneider HP, et al. Uterine perfusion and endometrial thickness in postmenopausal women on long-term continuous combined estrogen and progestogen replacement. Ultrasound Obstet Gynecol 1997;9:113-119.
47. Cheng WF, Lin HH, Torng PL, et al. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated pre-menopausal and postmenopausal breast cancer patients. Gynecol Oncol 1997;66:233-237.
48. American College of Obstetricians and Gynecologists. Committee on Gynecologic Practice: Tamoxifen and endometrial cancer. Int J Gynecol Obstet 1996;53:197-199.
49. Landis SH, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1999;49:8-31.
50. Dubinsky TJ, Parvey HR, Maklad N. The role of transvaginal sonography and endometrial biopsy in the evaluation of peri- and postmenopausal bleeding. Am J Roentgenol 1997;169:145-149.
51. Ascher SM, Johnson JC, Bames WA, et al. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: Histopathologic correlation. Radiology 1996;200:105-110.
52. Letterie GS, Haggerty MF. Magnetic resonance imaging of intrauterine synechiae. Gynecol Obstet Invest 1994;37:66-68.
53. Bacelar AC, Wilcock D, Powell M, et al. The value of MRI in the assessment of traumatic intra-uterine adhesions (Asherman's syndrome). Clin Radiol 1995;50:80-83.
54. Audet P, Pressacco J, Burke M, et al. MR imaging of female pelvic malignancies. Magn Reson Imaging Clin N Am 2000;8:887-914.
55. Hernandez E. Endometrial adenocarcinoma: A primer for the generalist. Obstet Gynecol Clin North Am 2001;28:743-757.
56. Goldstein SR, Nachtigall M, Snyder JR, et al. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 1990;163(1 pt 1):119-123.
57. Ichikawa Y, Takano K, Higa S, et al. Endometrial carcinoma coexisting with pregnancy, presumed to derive from adenomyosis. Int J Gynecol Cancer 2001; 11:488-490.
58. Hernandez E, Woodruff JD. Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 1980;138:827-832.
59. Creasman WT, Morrow CP, Bundy L. The surgical pathologic spread pattern of endometrial cancer: A gynecologic oncology group study. Cancer 1987;60:2035-2041.
60. Rose PG. Endometrial carcinoma. N Engl J Med 1996;335:640-649.
61. Piver MS, Lele SB, Barlow JJ, et al. Para aortic lymph node evaluation in Stage 1 endometrial carcinoma. Obstet Gynecol 1982;59: 97-100.
62. Larson DM, Connor GP, Broste SK, et al. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88:394-398.
63. Hording U, Hansen U. Stage I endometrial carcinoma: A review of 140 patients primarily treated by surgery only. Gynecol Oncol 1985;22:51-58.
64. Calais G, Vitu L, Descarps P, et al. Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II. Int J Radiat Oncol Biol Phys 1990;19:523-527.
65. Ascher SM, Takahama J, Jha R. Staging of gynecologic malignancies. Top Magn Reson Imaging 2001;12:105-129.
66. Mayr NA, Wen BC, Benda J, et al. Postoperative radiation therapy in clinical stage I endometrial cancer: Corpus, cervical, and lower uterine segment involvement - Patterns of failure. Radiology 1995; 196:323-328.
67. DelMaschio A, Vanzulli A, Sironi S, et al. Estimating the depth of myometrial involvement by endometrial carcinoma: Efficacy of transvaginal sonography versus MR imaging. Am J Roentgenol 1993;160:533-538.
68. Walsh JW, Goplerund DR. Computed tomography of primary, persistent, and recurrent endometrial malignancy. Am J Roentgenol 1982;139:1149-1154.
69. Saez F, Urresola A, Larena JA, et al. Endometrial carcinoma: Assessment of myometrial invasion with plain and gadolinium-enhanced MR imaging. J Magn Reson Imaging 2000;12:460-466.
70. Kim SH, Kim HD, Song YS, et al. Detection of deep myometrial invasion in endometrial carcinoma: Comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr 1995;19:766-772.
71. Hardesty LA, Sumkin JH, Nath ME, et al. Use of preoperative MR imaging in the management of endometrial carcinoma: Cost analysis. Radiology 2000;215:45-49.
72. Wiesenfeld U, Cova M, De Lazslo P, et al. Magnetic resonance (MR) in endometrial carcinoma preoperative evaluation. Minerva Ginecol 2001;53:341-346.
73. Cunha TM, Felix A, Cabral I. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and gross visual inspection. Int J Gynecol Cancer 2001;11:130-136.
74. Gandolfo N, Gandolfo NG, Serafini G, et al. Endometrial stromal sarcoma of the uterus: MR and US findings. Eur Radiol 2000;10: 776-779.
75. Hricak H, Hamm B, Semelka RC, et al. Carcinoma of the uterus: Use of gadopentetate dimeglumine in MR imaging. Radiology 1991;181:95-106.
76. Sironi S, Colombo E, Villa G, et al. Myometrial invasion by endometrial carcinoma: Assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992;185:207-212.
77. Yamashita Y, Mizutani H, Torashima M, et al. Assessment of myometrial invasion by endometrial carcinoma transvaginal sonography versus contrast-enhanced MR imaging. Am J Roentgenol 1993;161:595-599.
78. Frei KA, Kinkel K. Staging endometrial cancer: Role of magnetic resonance imaging. J Magn Reson Imaging 2001;13:850-855.
79. Imaoka I, Sugimura K, Masui T, et al. Abnormal uterine cavity: Differential diagnosis with MR imaging. Magn Reson Imaging 1999;17:1445-1455.
80. Kobayashi S, Takeda K, Sakuma H, et al. Uterine neoplasms: Magnetization transfer analysis of MR images. Radiology 1997;203: 377-382.
81. Lee EJ, Byun JY, Kim BS, et al. Staging of early endometrial carcinoma: Assessment with T2-weighted and gadolinium-enhanced T1-weighted MR Imaging. Radiographics 1999; 19:937-945.
82. Ascher SM, Scoutt LM, McCarthy SM, et al. Uterine changes after dilation and curettage: MR imaging findings. Radiology 1991;180: 433-435.
83. Szklaruk J, Tamm EP, Choi H, et al. MR imaging of common and uncommon large pelvic masses. Radiographics 2003;23:403-424.
84. American Joint Committee on Cancer. Manual for Staging of Cancer, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1988;157-159.
85. Joja I, Asakawa T, Shiraiwa M, et al. Endometrial carcinoma: Multisection dynamic MR imaging using a three-dimensional FLASH technique during breath holding. Radiat Med 1999;17: 211-218.
86. Joja I, Asakawa M, Asakawa T, et al. Endometrial carcinoma: Dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 1996;20:878-887.
87. Savci G, Ozyaman T, Tutar M, et al. Assessment of depth of myometrial invasion by endometrial carcinoma: Comparison of T2-weighted SE and contrast-enhanced dynamic GRE MR imaging. Eur Radiol 1998;8:218-223.
88. Takahashi S, Murakami T, Narumi Y, et al. Preoperative staging of endometrial carcinoma: Diagnostic effect of T2-weighted fast spin-echo MR imaging. Radiology 1998;206:539-547.
89. Seki H, Takano T, Sakai K. Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. Am J Roentgenol 2000;175:171-176.
90. Murakami T, Kurachi H, Nakamura H, et al. Cervical invasion of endometrial carcinoma - Evaluafion by parasagittal MR imaging. Acta Radiol 1995;36:248-253.
91. Shibutani O, Joja I, Shiraiwa M, et al. Endometrial carcinoma: Efficacy of thin-section oblique axial MR images for evaluafing cervical invasion. Abdom Imaging 1999;24:520-526.
92. Roy C, Le Bras Y, Mangold L, et al. Small pelvic lymph node metastases: Evaluation with MR imaging. Clin Radiol 1997;52: 437-440.
93. Yazigi R, Cohen J, Munoz AK, et al. Magnetic resonance imaging determination of myometrial invasion in endometrial carcinoma. Gynecol Oncol 1989;34:94-97.
94. Chen SS, Rumancik WM, Spiegel G. Magnetic resonance imaging in Stage I endometrial carcinoma. Obstet Gynecol 1990;75:274-277.
95. Sahdev A, Sohaib SA, Jacobs I, et al. MR imaging of uterine sarcomas. Am J Roentgenol 2001;177:1307-1311.
96. Ueda M, Otsuka M, Hatakenaka M, et al. MR imaging findings of uterine endometrial stromal sarcoma: Differentiation from endometrial carcinoma. Eur Radiol 2001;11:28-33.
97. Kahanpaa KV, Wahlstrom T, Grohn P, et al. Sarcomas of the uterus: A clinicopathologic study of 119 patients. Obstet Gynecol 1986;67:417-424.
98. Koyama T, Togashi K, Konishi I, et al. MR imaging of endometrial stromal sarcoma: Correlation with pathologic findings. Am J Roentgenol 1999;173:767-772.
99. La Fianza A, Meloni G, Alberici E, et al. Magnetic resonance appearance of endometrial sarcoma: Report of a case with unusual findings. Magn Reson Imaging 1999;17:637-640.
100. Ueda M, Otsuka M, Hatakenaka M, et al. Uterine endometrial stromal sarcoma located in uterine myometrium: MRI appearance. Eur Radiol 2000;10:780-782.